Application of Multi-criteria Decision Making Approach and Experimental Design and Development of Stability-indicating UPLC Method for Simultaneous Determination of Losartan Potassium and Hydrochlorothiazide in Bulk and Tablet Dosage Form
Hamed Hamed Abu Seada, Khalid Abdelsalam Attia, Mohammed Wafaa Nassar, Adel Mohammed Ahmed
Chemical Science International Journal · pp. 102–119 · Published 18 Apr 2015
10.9734/ACSJ/2015/16233Abstract
This paper describes a multi response optimization methodology in combination with experimental design as a powerful technique for development of a RP-UPLC method for the simultaneous determination of losartan potassium and hydrochlorothiazide in combined dosage forms. The response surface design by means of 24 full factorial design was used taking resolution, symmetry of two peaks, and two retention factors as the responses with four important factors, pH of the mobile phase, percentage of the organic modifier, buffer concentration and column temperature, were used to design mathematical models. Derringer’s desirability function was used for reaching a suitable compromise among the responses. Optimal conditions included mobile phase consisting of acetonitrile–acetate buffer 38:62 v/v, pH 5.25 and buffer concentration of 28 mM as the mobile phase and at a flow rate of 0.3 ml/min and a column temperature of 37°C. The calibration plot was linear over the concentration ranges of 0.05–7 µg/mL for Losartan and 0.0125-4 µg/mL for hydrochlorothiazide having correlation coefficients not less than 0.999. Limits of detection and quantification were 0.287, 0.869 µg/mL and 0.487, 1.47 µg/mL, for Losartan and hydrochlorothiazide respectively. The specificity and stability-indicating capability of the method was proven through forced degradation studies, which showed no interference of the excipients. The robustness of the method was evaluated by Youden and Steiner’s robustness test. The method is simple, rapid, and robust for simultaneous determination of losartan potassium and hydrochlorothiazide with minimum amount of solvent mobile phase and shortest run time about 4.5 min.
References (36)
- 1 Response Surface Methodology: Process and Product Optimization Using Designed Experiments [DOI]
- 2 Experimental design and optimization [DOI]
- 3 Angiotensin II receptor antagonists [DOI]
- 4 Statistical media optimization and alkaline protease production from Bacillus mojavensis in a bioreactor [DOI]
- 5 Statistical Manual of the Association of Official Analytical Chemists
- 6 Comparison of ultra-performance liquid chromatography and high-performance liquid chromatography for the determination of priority pesticides in baby foods by tandem quadrupole mass spectrometry [DOI]
- 7 Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection [DOI]
- 8 Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution [DOI]
- 9 Multi-criteria decision making approach and experimental design as chemometric tools to optimize HPLC separation of domperidone and pantoprazole [DOI]
- 10 Electrochemical study of hydrochlorothiazide and its determination in urine and tablets [DOI]
- 11 Development and validation of a stability-indicating HPLC method for the simultaneous determination of Losartan potassium, hydrochlorothiazide, and their degradation products [DOI]
- 12 Simultaneous determination of losartan and hydrochlorothiazide in tablets by high-performance liquid chromatography [DOI]
- 13 Optimization and validation of a capillary zone electrophoretic method for the analysis of several angiotensin-II-receptor antagonists [DOI]
- 14 Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatography [DOI]
- 15 Determination of losartan and its degradates in COZAAR® tablets by reversed-phase high-performance thin-layer chromatography [DOI]
- 16 Identification of losartan degradates in stressed tablets by LC-MS and LC-MS/MS [DOI]
- 17 Development and validation of an UV derivative spectrophotometric determination of Losartan potassium in tablets [DOI]
- 18 Determination of losartan and hydrochlorothiazide in tablets by CE and CEC [DOI]
- 19 Stability study of losartan/hydrochlorothiazide tablets [DOI]
- 20 Spectrofluorimetric method for determination of some angiotensin II receptor antagonists [DOI]
- 21 Determination of Losartan and Triamterene in Pharmaceutical Compounds and Urine Using Cathodic Adsorptive Stripping Voltammetry [DOI]
- 22 Comparison of liquid chromatography, capillary electrophoresis and super-critical fluid chromatography in the determination of Losartan Potassium drug substance in Cozaar® tablets [DOI]
- 23 A rapid colorimetric method for the determination of Losartan potassium in bulk and in synthetic mixture for solid dosage form [DOI]
- 24 Simultaneous determination of moexipril hydrochloride and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid chromatographic methods [DOI]
- 25 Chemometric technique for the optimization of chromatographic system: Simultaneous HPLC determination of Rosuvastatin, Telmisartan, Ezetimibe and Atorvastatin used in combined cardiovascular therapy [DOI]
- 26 Application of desirability function for optimizing the performance characteristics of carbonitrided bushes [DOI]
- 27 Development of a HPLC method for the simultaneous determination of losartan potassium and atenolol in tablets [DOI]
- 28 Comparison of UPLC and HPLC for Analysis of Dietary Folates [DOI]
- 29 Combined effect of polarity and pH on the chromatographic behavior of some angiotensin II receptor antagonists and optimization of their determination in pharmaceutical dosage forms [DOI]
- 30 Multiobjective Optimization Approach in Evaluation of Chromatographic Behaviour of Zolpidem Tartrate and Its Degradation Products [DOI]
- 31 Sensitive and selective liquid chromatography–electrospray ionization tandem mass spectrometry analysis of hydrochlorothiazide in rat plasma [DOI]
- 32 An Improved HPLC Method for Simultaneous Analysis of Losartan Potassium and Hydrochlorothiazide with the Aid of a Chemometric Protocol [DOI]
- 33 Simultaneous spectrophotometric determination of losartan potassium and hydrochlorothiazide in tablets
- 34 Development Of A RP-HPLC Method For Evaluating Losartan Potassium and Hydrochlorthiazide Tablets
- 35 Statistical design and analysis of experiments: with applications to engineering and science [DOI]
- 36 HPLC, a practical user's guide [DOI]
Cited by 1
H. Mohammed, Dhafer S. Alsahabi, Amira M. Hegazy · Foods · 2023
Related research
- A Review on Bioanalytical Method Development and Validation for Estimation of Drugs by Using Hyphenated Techniques and its Applications on Routine Analysis — shares topic coverage
- Sildenafil Determination by Using UPLC in Different Italian Viagra Tablets — shares topic coverage
- Rapid, Simple and Validated Method for Estimation of Zolpidem by UPLC in Tablet Dosage Form — shares topic coverage
- Stability-Indicating RP-UPLC Method Development and Validation for the Process Related Impurities of Nebivolol and Structural Characterization of Its Forced Degradation Products by LC-MS/MS — shares topic coverage
- Development and Validation of New RP-UPLC Method for the Quantitative Analysis of Mycophenolate in Tablet Dosage Form — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.